C
Convelo Therapeutics
Innovative medicines unlocking the regenerative capacity of the central nervous system
About Convelo Therapeutics
Convelo Therapeutics is a biotechnology company focused on developing groundbreaking medicines that stimulate the regenerative capacity of the central nervous system (CNS). The company operates in the biotechnology and pharmaceutical markets, targeting neurological disorders that currently lack effective treatments. Convelo's innovative platform identifies novel candidate treatments capable of directly stimulating stem cells in the CNS to form new myelin, a critical component for nerve function. This approach aims to address unmet medical needs in conditions such as multiple sclerosis and other demyelinating diseases.
Convelo Therapeutics primarily serves patients suffering from neurological disorders, healthcare providers, and pharmaceutical companies looking for advanced treatment options. The business model revolves around research and development (R&D) of proprietary medicines, which are then brought to market through partnerships, licensing agreements, or direct commercialization. Revenue is generated through these partnerships, licensing deals, and eventual sales of approved therapies.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Dec 2022 | $11M | $43M | Undisclosed | ↗ |
| FundingOther financing | Aug 2018 | $7.8M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Convelo Therapeutics is 600 monthly website visits, down 50% over the last three months. Convelo Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Convelo Therapeutics in the Cleveland ecosystem
The Convelo Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors3 additional known investors
Case Western Reserve University
JobsOhio Ventures
JumpStart Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Convelo Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Convelo Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










